⌘+K

Pulse Explore Communities Researchers Journals

Home Communities Explore

February 26, 2024Frontiers in ImmunologyOpen Access

Reduced toxicity matched sibling bone marrow transplant results in excellent outcomes for severe congenital neutropenia

Joseph H. Oved Nora M. Gibson Kimberly Venella Caitlin W. Elgarten Lisa Wray Julia T. Warren Timothy S. Olson

View Full Paper

Ask AI

Bookmark

Share

No abstract yet

We only have this paper's title and publication details.

Read it at the source→

Abstract

Severe congenital neutropenia (SCN) is caused by germline mutations, most commonly in

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Oved et al. (2024) studied this question.

synapsesocial.com/papers/68e778d3b6db6435876ed5cf https://doi.org/10.3389/fimmu.2024.1369243

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Successful Bone Marrow Transplantation in a Patient with Acute Myeloid Leukemia Developed from Severe Congenital Neutropenia Using Modified Chemotherapy and Conditioning Regimen for Leukemia2024 · 3 citations
2Evaluation of bone mineral density in patients with severe congenital neutropenia: experience of six centers in TurkeyCohort Study · 2026
3Single-cell immunophenotyping reveals mutation-specific immune alterations in severe congenital neutropenia2025
4Oral health management in children with severe congenital neutropenia with periodontitis: Case report2024 · 4 citations
5Genetic backgrounds and clinical characteristics of congenital neutropenias in <scp>Israel</scp>2024 · 3 citations

More related papers

Nonmyeloablative stem cell transplantation for congenital immunodeficiencies2000
Prevention and control of infections in patients with severe congenital neutropenia; a follow up study.2012
Clinical outcome and infectious complications in genetic and suspected genetic neutropenia: A report from the Canadian Inherited Marrow Failure Registry2026

More from Frontiers in Immunology

Beyond eosinophil depletion: long-term clinical trajectory and durability of response to benralizumab in patients with severe eosinophilic asthma and CRSwNP: an 18-month real-world study (the BANDOR study)Mon,
Yixintai granules enhance glucose and lipid metabolism after ischemic heart failure by regulating inflammatory factors via the LPS/TLR4/NF-κB signaling pathwayFri,